Evaluating the Impact of an Intervention Module on Reducing Physical Side Effects in Breast Cancer Patients Undergoing Chemotherapy

Main Article Content

Suhasinee Subramaniam
Sherina Mohd Sidik
Lekhraj Rampal
Kulanthayan K.C. Mani
Siti Irma Fadhilah
Ummavathy Periasamy

Abstract

Introduction: Cancer remains one of the leading causes of morbidity and mortality worldwide, with breast cancer being one of the most prevalent forms affecting women globally. This study aims to develop, implement, and evaluate the effectiveness of an intervention module designed to reduce the physical effects experienced by breast cancer patients undergoing chemotherapy at the Institute Kanser Negara (National Cancer Institute). Methods: A single-blinded Randomized Controlled Clinical Trial was conducted at Institut Kanser Negara between January 2023 and Jun 2023. The estimated sample size was 120 participants, with 60 participants in both the intervention and control groups. The intervention group received chemotherapy counseling using a newly developed module over three chemotherapy cycles. Result: The counselling module was effective in reducing the physical side effects among breast cancer patients undergoing chemotherapy at baseline and for three consecutive follow-ups . There was also a moderate effect reduction for physical side effects such as nausea (p< 0.001, partial Ƞ2 = 0.522), vomiting (p < 0.001, partial Ƞ2 = 0.519), diarrhea (p < 0.001, partial Ƞ2 = 0.389), constipation (p < 0.001, partial Ƞ2 = 0.226), fatigue (p < 0.001, partial Ƞ2 = 0.319), hair loss (p = 0.256, partial Ƞ2 = 0.011), mouth, gum and throat infection (p < 0.001, partial Ƞ2 = 0.237), skin and nail changes (p <0.001, partial Ƞ2 = 0.145). Conclusion: The intervention module with repetitive counseling sessions conducted by a pharmacist effectively reduced physical side effects in breast cancer patients undergoing chemotherapy.

Downloads

Download data is not yet available.

Article Details

How to Cite
Subramaniam, S., Mohd Sidik, S., Rampal, L., K.C. Mani, K., Siti Irma Fadhilah, & Periasamy, U. (2025). Evaluating the Impact of an Intervention Module on Reducing Physical Side Effects in Breast Cancer Patients Undergoing Chemotherapy. Malaysian Journal of Medicine and Health Sciences, 21(6), 1395.1 –1395.13. https://doi.org/10.47836/mjmhs.v21.i6.1395
Section
Original Articles

References

WHO. Global Health Observatory (Internet). 2023 (cited 2023 Jun 15). Available from: https://www.who.int/news-room/fact-sheets/detail/breast-cancer

Azizah AM, Hashimah B, Nirmal K, Siti Zubaidah AR, Puteri NA, Nabihah A, et al. Malaysia National Cancer Registry Report (MNCR) 2012-2016. National Cancer Registry Department, National Cancer Institute, Ministry of Health, Malaysia; 2019 (cited 2024 Feb 19). Available from: https://www.moh.gov.my/moh/resources/Penerbitan/Laporan/Umum/2012-2016%20(MNCRR)/MNCR_2012-2016_FINAL_(PUBLISHED_2019).pdf

Waks AG, Winer EP. Breast cancer treatment: A review. JAMA. 2019;321(3):288-300. doi: 10.1001/jama.2018.19323.

Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P, et al. Breast cancer. Nat Rev Dis Primers. 2019;5(1):66. doi: 10.1038/s41572-019-0111-2.

Rakhshani T, Dada M, Kashfi SM, Kamyab A, Jeihooni AK. The effect of educational intervention on knowledge, attitude, and practice of women towards breast cancer screening. Int J Breast Cancer. 2022;2022:5697739. doi: 10.1155/2022/5697739.

Ng CG, Mohamed S, Kaur K, Sulaiman AH, Zainal NZ, Taib NA, et al. Perceived distress and its association with depression and anxiety in breast cancer patients. PLoS One. 2017;12(3). https://doi.org/10.1371/journal.pone.0172975

Iddrisu M, Aziato L, Dedey F. Psychological and physical effects of breast cancer diagnosis and treatment on young Ghanaian women: A qualitative study. BMC Psychiatry. 2020;20(1):353. doi: 10.1186/s12888-020-02760-4.

Periasamy U, Mohd Sidik S, Rampal L. Managing Patients on Chemotherapy. 1st ed. Kuala Lumpur: University Putra Malaysia; 2015.

Dang CC, Amiruddin M, Lai SS, Chan SY. An emerging role of pharmacist in pre-chemotherapy counseling among breast cancer patients. Indian J Pharm Sci (Internet). 2017 (cited 2023 Dec 18). doi: 10.4172/pharmaceutical-sciences.1000228

Quinn CS, Bergsbaken JJ, Blessinger EJ, Piccolo JK. Implementation of a clinical pharmacist-led service to optimize management of refractory chemotherapy-induced nausea and vomiting in adult hematology/oncology clinic. J Oncol Pharm Pract. 2022;28(7):1499-1507. doi: 10.1177/10781552211029702

Tezcan S, İzzettin FV, Sancar M, Turhal NS, Yumuk PF. Role of clinical oncology pharmacist in determination of pharmaceutical care needs in patients with colorectal cancer. Eur J Hosp Pharm. 2018;25(e1). doi: 10.1136/ejhpharm-2016-001188.

Wickham RJ. Managing Constipation in Adults with Cancer. J Adv Pract Oncol. 2017;8(2):149-161.

Homan MJ, Reid JH, Nachar VR, Benitez LL, Brown AM, Kraft S, Hough S, Christen C, Frame D, McDevitt RL. Implementation and outcomes of a pharmacist-led collaborative drug therapy management program for oncology symptom management. Support Care Cancer. 2021;29(11):6505-6510. doi: 10.1007/s00520-021-06239-0

Flynn KN, Gochett C. Impact of Pharmacist-Driven Educational Intervention on Documentation of Bowel Function Assessment in Patients with Cancer Who Are Using Opioids. J Hematol Oncol Pharm. 2018;8(1).

Animaw L, Woldegiorgis Abate T, Endeshaw D, Tsegaye D. Fatigue and associated factors among adult cancer patients receiving cancer treatment at oncology unit in Amhara region, Ethiopia. PLoS One. 2023;18(1). doi: 10.1371/journal.pone.0279628

Waart HV, Stuiver MM, van Harten WH, Geleijn E, Kieffer JM, Buffart LM, et al. Effect of low-intensity physical activity and moderate-to high-intensity physical exercise during adjuvant chemotherapy on physical fitness, fatigue, and chemotherapy completion rates: results of the PACES randomized clinical trial. J Clin Oncol. 2015;33(17):1918-1927. doi: 10.1200/JCO.2014.59.1081

Freites-Martinez A, Shapiro J, Goldfarb S, Nangia J, Jimenez JJ, Paus R, Lacouture ME. Hair disorders in patients with cancer. J Am Acad Dermatol. 2019;80:1179–1196. doi: 10.1016/j.jaad.2018.03.055.

Saraswat N, Chopra A, Sood A, Kamboj P, Kumar S. A descriptive study to analyze chemotherapy-induced hair loss and its psychosocial impact in adults: Our experience from a tertiary care hospital. Indian Dermatol Online J. 2019;10(4):426–430. doi: 10.4103/idoj.IDOJ_471_18

Tanaka K, Hori A, Tachi T, Osawa T, Nagaya K, Makino T, et al. Impact of pharmacist counseling on reducing instances of adverse events that can affect the quality of life of chemotherapy outpatients with breast Cancer. J Pharm Health Care Sci. 2018;4:1-14. doi: https://doi.org/10.1186/s40780-018-0105-3

Rubio-Gonzalez B, Juhász M, Fortman J, Mesinkovska NA. Pathogenesis and treatment options for chemotherapy-induced alopecia: a systematic review. Int J Dermatol. 2018;57(12):1417-1424. doi: https://doi.org/10.1111/ijd.13906

Bhoyrul, B., Asfour, L., Lutz, G., Mitchell, L., Jerjen, R., Sinclair, R. D., ... & Harries, M. J. (2021). Clinicopathologic characteristics and response to treatment of persistent chemotherapy-induced alopecia in breast cancer survivors. JAMA dermatology, 157(11), 1335-1342. doi: 10.1001/jamadermatol.2021.3676

Iihara H, Hirose C, Funaguchi N, Endo J, Ito F, Yanase K, et al. Evaluation of clinical pharmacist interventions for adverse events in hospitalized patients with thoracic cancer receiving cancer chemotherapy. Mol Clin Oncol. 2021;14(6):1-8. doi: 10.3892/mco.2021.2278

Barkokebas A, Silva IHM, de Andrade SC, Carvalho AAT, Gueiros LAM, Paiva SM, et al. Impact of oral mucositis on oral‐health‐related quality of life of patients diagnosed with cancer. J Oral Pathol Med. 2015;44(9):746-751. doi: 10.1111/jop.12282

Zawar V, Bondarde S, Pawar M, Sankalecha S. Nail changes due to chemotherapy: a prospective observational study of 129 patients. J Eur Acad Dermatol Venereol. 2019;33(7):1398-1404. doi: 10.1111/jdv.15508

Trivedi M, Mehta RD, Kumar HS, Ghiya BC, Soni P, Meena MK, et al. Nail changes caused by chemotherapy among cancer patients: A cross-sectional study of northwest Rajasthan. Indian Dermatol Online J. 2020;11(6):953. doi: 10.4103/idoj.IDOJ_84_20

Mittal S, Khunger N, Kataria SP. Nail Changes With Chemotherapeutic Agents and Targeted Therapies. Indian Dermatol Online J. 2022;13(1):13–22. doi: 10.4103/idoj.IDOJ_801_20.

Ibrahim NA, Björnsdottir I, Al Alwan AS, Honore PH. Insights about health-related quality of life in cancer patients indicate demands for better pharmaceutical care. J Oncol Pharm Pract. 2014;20(4):270-277. doi: 10.1177/1078155213505255

Periasamy U, Sherina MS, Akhtari-Zavare M, Rampal L, Ismail SIF, Mahmud R. Effects of counselling on quality of life among Cancer patients in Malaysia: a randomized controlled trial. Iran J Public Health. 2020;49(10):1902. doi: 10.18502/ijph.v49i10.4693

National Cancer Institute (2009). Common terminology criteria for adverse events (CTCAE) v4.0. Retrieved from https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03/Archive/CTCAE_4.0_2009-05-29_QuickReference_8.5x11.pdf